KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Depreciation & Amortization - TotalEPS (Basic)EPS (Weighted Average and Diluted)Equity IncomeIncome from Non-Controlling InterestsInterest ExpensesNet Income towards Common StockholdersNon Operating Investment IncomeOperating ExpensesOther Operating ExpensesPreferred Dividend PaymentsProfit After TaxRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)
Others
Ratios

National Health Investors (NHI) Consolidated Net Income (2016 - 2019)

Historic Consolidated Net Income for National Health Investors (NHI) over the last 10 years, with Q3 2019 value amounting to $28.1 million.

  • National Health Investors' Consolidated Net Income fell 178.64% to $28.1 million in Q3 2019 from the same period last year, while for Jun 2020 it was $28.1 million, marking a year-over-year decrease of 6351.33%. This contributed to the annual value of $161.3 million for FY2019, which is 399.88% up from last year.
  • As of Q3 2019, National Health Investors' Consolidated Net Income stood at $28.1 million, which was down 178.64% from $26.2 million recorded in Q2 2019.
  • Over the past 5 years, National Health Investors' Consolidated Net Income peaked at $35.0 million during Q4 2016, and registered a low of $18.6 million during Q2 2016.
  • Moreover, its 5-year median value for Consolidated Net Income was $28.1 million (2019), whereas its average is $28.3 million.
  • As far as peak fluctuations go, National Health Investors' Consolidated Net Income tumbled by 4133.79% in 2016, and later soared by 4305.91% in 2017.
  • Over the past 5 years, National Health Investors' Consolidated Net Income (Quarter) stood at $31.9 million in 2015, then increased by 9.69% to $35.0 million in 2016, then fell by 20.48% to $27.8 million in 2017, then increased by 2.74% to $28.6 million in 2018, then fell by 1.79% to $28.1 million in 2019.
  • Its Consolidated Net Income stands at $28.1 million for Q3 2019, versus $26.2 million for Q2 2019 and $22.2 million for Q1 2019.